The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA2059156
Max Phase: Preclinical
Molecular Formula: C12H15BrN4O3
Molecular Weight: 343.18
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: Nc1ncc(Br)c2c1ncn2[C@@H]1C[C@H](CO)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C12H15BrN4O3/c13-6-2-15-12(14)8-9(6)17(4-16-8)7-1-5(3-18)10(19)11(7)20/h2,4-5,7,10-11,18-20H,1,3H2,(H2,14,15)/t5-,7-,10-,11+/m1/s1
Standard InChI Key: WCQHGFZOJHBINT-OFBQIVOGSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 343.18Molecular Weight (Monoisotopic): 342.0328AlogP: 0.05#Rotatable Bonds: 2Polar Surface Area: 117.42Molecular Species: NEUTRALHBA: 7HBD: 4#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): 0CX Acidic pKa: 13.33CX Basic pKa: 5.21CX LogP: -1.03CX LogD: -1.03Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.61Np Likeness Score: 0.93
References 1. Liu C, Chen Q, Schneller SW.. (2012) 3-Bromo-3-deazaneplanocin and 3-bromo-3-deazaaristeromycin: synthesis and antiviral activity., 22 (16): [PMID:22795626 ] [10.1016/j.bmcl.2012.06.075 ]